Market Insights Health Medical Technology Medical Devices

Diabetes Care Devices - South America

South America

In South America, revenue in the Diabetes Care Devices market market is projected to reach US$1.12bn in 2024.
The revenue is anticipated to exhibit an annual growth rate (CAGR 2024-2029) of 12.52%, which will result in a market volume of US$2.02bn by 2029.
In a global context, the majority of revenue will be generated the United States, which is expected to reach US$11,710.00m in 2024.
In South America, the demand for advanced diabetes care devices is surging due to an increasing prevalence of diabetes and a growing emphasis on personalized healthcare solutions.

Key regions: Netherlands, Japan, France, Italy, China

Market

Region

Region comparison

Currency

Analyst Opinion

The Diabetes Care Devices Market in South America is witnessing considerable growth, fueled by factors such as increasing prevalence of diabetes, advancements in technology, and heightened awareness of diabetes management among patients and healthcare providers.

Customer preferences: In South America, consumers are increasingly prioritizing personalized diabetes management solutions, reflecting a growing demand for smart glucose monitoring devices that integrate with mobile applications. This trend is influenced by a younger demographic that values technology and convenience, as well as cultural shifts towards proactive health management. Additionally, there is rising interest in educational resources and community support networks, fostering a more informed patient population that seeks comprehensive care options beyond traditional methods.

Trends in the market: In South America, the Diabetes Care Devices Market is experiencing a significant shift towards advanced digital solutions, characterized by an increasing adoption of continuous glucose monitors (CGMs) and insulin delivery systems that leverage mobile technology. This trend is propelled by a tech-savvy younger population eager for innovative health management tools. Furthermore, the integration of AI-driven analytics in diabetes management is gaining traction, enabling personalized treatment plans. As awareness of diabetes complications rises, industry stakeholders must adapt by investing in user-friendly devices and educational platforms to cater to the evolving needs of patients, fostering a more engaged and informed community.

Local special circumstances: In South America, the Diabetes Care Devices Market is uniquely influenced by diverse geographical and cultural factors, as well as varying regulatory environments across countries. For instance, Brazil's expansive territory presents challenges in healthcare accessibility, prompting a surge in mobile health solutions that reach remote populations. Additionally, cultural attitudes toward health management differ significantly, with a strong emphasis on community support and education impacting device adoption rates. Regulatory frameworks also vary, with some countries promoting faster approval processes for innovative devices, thereby fostering a dynamic market landscape that encourages local startups and international collaborations.

Underlying macroeconomic factors: The Diabetes Care Devices Market in South America is significantly shaped by macroeconomic factors including national economic stability, healthcare expenditure, and investment in technology. Countries with robust economic growth, like Chile and Colombia, are witnessing increased government spending on healthcare infrastructure, which enhances access to diabetes care devices. Conversely, economic volatility in regions such as Venezuela can hinder market expansion. Additionally, the rising prevalence of diabetes, driven by lifestyle changes and urbanization, fuels demand for innovative devices. Regulatory support also plays a critical role, as nations that streamline approval processes encourage investment and foster a competitive landscape for medical technology firms.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.